Cell-type specific cis-eQTLs in eight brain cell-types identifies novel risk genes for human brain disorders
read more
Citations
The missing link between genetic association and regulatory function
Single nuclei RNAseq stratifies multiple sclerosis patients into three distinct white matter glia responses
Using Stem Cell Models to Explore the Genetics Underlying Psychiatric Disorders: Linking Risk Variants, Genes, and Biology in Brain Disease.
Convergent impact of schizophrenia risk genes
Inferring cell-type-specific causal gene regulatory networks during human neurogenesis
References
Controlling the false discovery rate: a practical and powerful approach to multiple testing
A global reference for human genetic variation.
In situ click chemistry generation of cyclooxygenase-2 inhibitors
The mutational constraint spectrum quantified from variation in 141,456 humans
glmmTMB Balances Speed and Flexibility Among Packages for Zero-inflated Generalized Linear Mixed Modeling
Related Papers (5)
Brain expression quantitative trait locus and network analysis reveals downstream effects and putative drivers for brain-related diseases
Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression.
Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases.
Frequently Asked Questions (11)
Q2. What are the future works mentioned in the paper "Cell-type specific cis-eqtls in eight brain cell-types identifies novel risk genes for human brain disorders" ?
In summary, their study provides a systematic investigation of eQTLs in cell-types of the adult human brain, defines a reference data set of CNS cell-type specific eQTLs and provides a foundational resource of high-confidence colocalized genes in disease-relevant cell types for robust future functional studies of neurodegenerative disease mechanisms using appropriate iPSC-based human cell models.
Q3. What is the role of CTSB in lysosomal degradation of PI?
CTSB plays an essential role in lysosomal degradation of α-synuclein 37, while TOMM7 is a small subunit of the TOM complex that is essential for the binding of PINK1 (a gene associated with monogenic forms of the disease) to the TOM complex.
Q4. What were the SNPs excluded from the Roche_AD dataset?
SNPs with imputation score <0.4 or with missingness greater than 5% were excluded, as well as individuals with more than 2% of missing genotypes.
Q5. How did SampleQC help us identify a subset of cells in many samples?
SampleQC allowed us to identify a subset of cells in many samples with both high splice ratios and high mitochondrial proportions (90% of reads being spliced), which were excluded.
Q6. What is the risk column for a cis-eQTL?
The risk column indicates whether an increase in gene expression leads to an increase in disease risk (red), a decrease in disease risk (blue) or whether the colocalization signal is due to a splicing QTL (orange).
Q7. Who provided inputs on the interpretation of the results?
VM and PDJ provided snucRNAseq and whole genome sequencing data on a subset of AD samples and provided critical inputs on the interpretation of the results.
Q8. What is the GWAS SNP that overlapped the PLEKHA1 gene?
INPP5D is a phosphatase which hydrolyze phosphatidylinositol-3,4,5-trisphosphate into phosphatidylinositol 3,4- diphosphate, which specifically binds to PLEKHA1 51, a gene recently associated with AD through proteome-wide association study 52.
Q9. What is the effect size of the cis-eQTLs?
Microglia showed strongest evidence for cell-type specific genetic effects with an estimate that 60-92% of the discovered cis-eQTLs have adifferent genetic effect in the other cell types, reflecting its unique developmental origin.
Q10. What was the qvalue statistic used to calculate the proportion of true alternative hypothesis?
Estimates of the proportion of true alternative hypothesis (i.e. proportion of genes with a cis-eQTL, Figure S2) was performed using the pi1 statistic from the qvalue R package 25.
Q11. What are the recent studies done using bulk human brain tissues?
most prior eQTL studies were done using bulk human brain tissues and have been partially successful in prioritizing disease risk genes by integrating GWAS results with tissue-level eQTLs.